[Maternal morbidity and mortality associated with conservative management for placenta morbidly adherent (accreta) diagnosed during pregnancy. Report of 15 cases].

Date publication

octobre 2016

Journal

Journal de gynecologie, obstetrique et biologie de la reproduction

Auteurs

Membres identifiés du Cancéropôle Est :
Pr AKLADIOS Chérif

Tous les auteurs :
Daney de Marcillac F, Lecointre L, Guillaume A, Sananes N, Fritz G, Viville B, Boudier E, Nisand I, Gaudineau A, Langer B, Akladios CY

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/27118678

Résumé

High risk of morbidly adherent placenta increased during past years. Their management is controversial. Cesarean hysterectomy, considered the gold standard treatment by American Society, is associated with high risk of maternal morbimortality. Conservative management has been sought to reduce maternal morbidity associated with caesarean hysterectomy while maintaining fertility. It consists of leaving the placenta in place but long-term monitoring. Our main objective was to determine advantage/disadvantage of conservative management on patient with an antenatal diagnosis of placenta accreta, increta or percreta.

Mots clés

Accreta/increta/percreta, Conservative management, Maternal morbimortality, Morbidly adherent placenta, Morbimortalité maternelle, Placenta anormalement adhérent, Traitement conservateur

Référence

J Gynecol Obstet Biol Reprod (Paris). 2016 10;45(8):849-858